Radiogenomics of clear cell renal cell carcinoma: preliminary findings of The Cancer Genome Atlas-Renal Cell Carcinoma (TCGA-RCC) Imaging Research Group

Verfasser / Beitragende:
[Atul Shinagare, Raghu Vikram, Carl Jaffe, Oguz Akin, Justin Kirby, Erich Huang, John Freymann, Nisha I. Sainani, Cheryl Sadow, Tharakeswara Bathala, Daniel Rubin, Aytekin Oto, Matthew Heller, Venkateswar Surabhi, Venkat Katabathina, Stuart Silverman]
Ort, Verlag, Jahr:
2015
Enthalten in:
Abdominal Imaging, 40/6(2015-08-01), 1684-1692
Format:
Artikel (online)
ID: 605492689
LEADER caa a22 4500
001 605492689
003 CHVBK
005 20210128100516.0
007 cr unu---uuuuu
008 210128e20150801xx s 000 0 eng
024 7 0 |a 10.1007/s00261-015-0386-z  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s00261-015-0386-z 
245 0 0 |a Radiogenomics of clear cell renal cell carcinoma: preliminary findings of The Cancer Genome Atlas-Renal Cell Carcinoma (TCGA-RCC) Imaging Research Group  |h [Elektronische Daten]  |c [Atul Shinagare, Raghu Vikram, Carl Jaffe, Oguz Akin, Justin Kirby, Erich Huang, John Freymann, Nisha I. Sainani, Cheryl Sadow, Tharakeswara Bathala, Daniel Rubin, Aytekin Oto, Matthew Heller, Venkateswar Surabhi, Venkat Katabathina, Stuart Silverman] 
520 3 |a Purpose: To investigate associations between imaging features and mutational status of clear cell renal cell carcinoma (ccRCC). Materials and methods: This multi-institutional, multi-reader study included 103 patients (77 men; median age 59years, range 34-79) with ccRCC examined with CT in 81 patients, MRI in 19, and both CT and MRI in three; images were downloaded from The Cancer Imaging Archive, an NCI-funded project for genome-mapping and analyses. Imaging features [size (mm), margin (well-defined or ill-defined), composition (solid or cystic), necrosis (for solid tumors: 0%, 1%-33%, 34%-66% or >66%), growth pattern (endophytic, <50% exophytic, or ≥50% exophytic), and calcification (present, absent, or indeterminate)] were reviewed independently by three readers blinded to mutational data. The association of imaging features with mutational status (VHL, BAP1, PBRM1, SETD2, KDM5C, and MUC4) was assessed. Results: Median tumor size was 49mm (range 14-162mm), 73 (71%) tumors had well-defined margins, 98 (95%) tumors were solid, 95 (92%) showed presence of necrosis, 46 (45%) had ≥50% exophytic component, and 18 (19.8%) had calcification. VHL (n=52) and PBRM1 (n=24) were the most common mutations. BAP1 mutation was associated with ill-defined margin and presence of calcification (p=0.02 and 0.002, respectively, Pearson's χ 2 test); MUC4 mutation was associated with an exophytic growth pattern (p=0.002, Mann-Whitney U test). Conclusions: BAP1 mutation was associated with ill-defined tumor margins and presence of calcification; MUC4 mutation was associated with exophytic growth. Given the known prognostic implications of BAP1 and MUC4 mutations, these results support using radiogenomics to aid in prognostication and management. 
540 |a Springer Science+Business Media New York, 2015 
690 7 |a Clear cell renal cell carcinoma  |2 nationallicence 
690 7 |a CT  |2 nationallicence 
690 7 |a MRI  |2 nationallicence 
690 7 |a Mutational status  |2 nationallicence 
690 7 |a Radiogenomics  |2 nationallicence 
700 1 |a Shinagare  |D Atul  |u Brigham and Women's Hospital, Boston, MA, USA  |4 aut 
700 1 |a Vikram  |D Raghu  |u University of Texas MD Anderson Cancer Center, Houston, TX, USA  |4 aut 
700 1 |a Jaffe  |D Carl  |u Boston Medical Center, Boston, MA, USA  |4 aut 
700 1 |a Akin  |D Oguz  |u Memorial Sloan Kettering Cancer Center, New York, NY, USA  |4 aut 
700 1 |a Kirby  |D Justin  |u National Cancer Institute, Bethesda, USA  |4 aut 
700 1 |a Huang  |D Erich  |u National Cancer Institute, Bethesda, USA  |4 aut 
700 1 |a Freymann  |D John  |u National Cancer Institute, Bethesda, USA  |4 aut 
700 1 |a Sainani  |D Nisha I.  |u Brigham and Women's Hospital, Boston, MA, USA  |4 aut 
700 1 |a Sadow  |D Cheryl  |u Brigham and Women's Hospital, Boston, MA, USA  |4 aut 
700 1 |a Bathala  |D Tharakeswara  |u University of Texas MD Anderson Cancer Center, Houston, TX, USA  |4 aut 
700 1 |a Rubin  |D Daniel  |u Stanford University School of Medicine, Stanford, CA, USA  |4 aut 
700 1 |a Oto  |D Aytekin  |u University of Chicago, Chicago, IL, USA  |4 aut 
700 1 |a Heller  |D Matthew  |u University of Pittsburgh Medical Center, Pittsburgh, PA, USA  |4 aut 
700 1 |a Surabhi  |D Venkateswar  |u University of Texas Health Science Center, Houston, TX, USA  |4 aut 
700 1 |a Katabathina  |D Venkat  |u University of Texas Health Science Center, San Antonio, TX, USA  |4 aut 
700 1 |a Silverman  |D Stuart  |u Brigham and Women's Hospital, Boston, MA, USA  |4 aut 
773 0 |t Abdominal Imaging  |d Springer US; http://www.springer-ny.com  |g 40/6(2015-08-01), 1684-1692  |x 0942-8925  |q 40:6<1684  |1 2015  |2 40  |o 261 
856 4 0 |u https://doi.org/10.1007/s00261-015-0386-z  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s00261-015-0386-z  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Shinagare  |D Atul  |u Brigham and Women's Hospital, Boston, MA, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Vikram  |D Raghu  |u University of Texas MD Anderson Cancer Center, Houston, TX, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Jaffe  |D Carl  |u Boston Medical Center, Boston, MA, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Akin  |D Oguz  |u Memorial Sloan Kettering Cancer Center, New York, NY, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Kirby  |D Justin  |u National Cancer Institute, Bethesda, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Huang  |D Erich  |u National Cancer Institute, Bethesda, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Freymann  |D John  |u National Cancer Institute, Bethesda, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Sainani  |D Nisha I.  |u Brigham and Women's Hospital, Boston, MA, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Sadow  |D Cheryl  |u Brigham and Women's Hospital, Boston, MA, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Bathala  |D Tharakeswara  |u University of Texas MD Anderson Cancer Center, Houston, TX, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Rubin  |D Daniel  |u Stanford University School of Medicine, Stanford, CA, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Oto  |D Aytekin  |u University of Chicago, Chicago, IL, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Heller  |D Matthew  |u University of Pittsburgh Medical Center, Pittsburgh, PA, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Surabhi  |D Venkateswar  |u University of Texas Health Science Center, Houston, TX, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Katabathina  |D Venkat  |u University of Texas Health Science Center, San Antonio, TX, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Silverman  |D Stuart  |u Brigham and Women's Hospital, Boston, MA, USA  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Abdominal Imaging  |d Springer US; http://www.springer-ny.com  |g 40/6(2015-08-01), 1684-1692  |x 0942-8925  |q 40:6<1684  |1 2015  |2 40  |o 261